-Top line data expected in second half of 2023- ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company…
Super UserJuly 21, 2022
Omicron is mutating in giant leaps, with scientists racing to keep up. Its diversity is challenging vaccine efficacy and complicating…
Super UserJuly 21, 2022
The grant focuses on a few areas across four years, including addressing health disparities. (more…)
Super UserJuly 21, 2022
GERMANTOWN, Md., July 19, 2022 /PRNewswire/ -- Deka Biosciences announced today that it is breaking ground on a 14,000 square…
Super UserJuly 21, 2022
On the heels of some big fundraising moves and in the hunt for a COVID-19 vaccine, Novavax is adding some…
Super UserJuly 21, 2022
GAITHERSBURG, Md., July 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for…
Super UserJuly 21, 2022
Progress Labs at Progress Way in Gaithersburg, MD is a two-building approximately 495,000 SF development situated on 44 acres with…
Super UserJuly 21, 2022
Maryland bucked a national trend in venture capital funding in the second quarter of 2022, recording an increase in the…
Super UserJuly 21, 2022
Baltimore biotechnology startup Delfi Diagnostics has raised $225 million as it embarks on a 15,000-person trial for its early cancer…
Super UserJuly 21, 2022